Exelixis
EXEL
#1695
Rank
$9.94 B
Marketcap
$34.83
Share price
0.52%
Change (1 day)
64.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company